Laboratory robotics market seen reaching $4.64 billion by 2030

The global laboratory robotics market was valued at $2.93 billion in 2025 and is projected to hit $4.64 billion by 2030, driven by automation demand in research and diagnostic labs. North America led the market in 2025, while Asia-Pacific is expected to grow fastest as labs adopt robotic systems, AI tools and high-throughput workflows.

Why it matters: - Laboratory robotics is becoming central to how research and diagnostic labs handle sample processing, liquid dispensing, mixing and analysis. - The shift reduces manual labor, improves reproducibility and supports faster high-throughput work. - Rising automation demand matters because labs are under pressure to deliver more precise results with fewer errors.

What happened: - The Business Research Company released a 2026 laboratory robotics market report covering global size, trends and forecasts through 2035. - The market was valued at $2.93 billion in 2025 and is expected to reach $3.22 billion in 2026. - The report projects the market will grow to $4.64 billion by 2030. - The forecast implies a 9.9% compound annual growth rate in the near term and 9.6% through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Laboratory robotics uses automated systems to perform routine and complex lab tasks. - Core uses include sample handling, liquid dispensing, mixing and analytical processes. - The systems are designed to improve accuracy, reproducibility and productivity. - The market’s historical growth was supported by manual sample handling, limited lab automation, high labor dependence, expanding research infrastructure and the need for consistent results. - Future growth is tied to advanced robotic arms, automated workstations, AI-driven workflow tools and cloud-based data visualization and analysis platforms. - Additional demand is coming from genomics, proteomics and clinical diagnostic facilities. - Key trends include wider use of automated liquid handling, LIMS integration, high-throughput screening and robotics for drug discovery and diagnostics. - The report says these applications aim to minimize human error and improve operational efficiency. - Research and clinical trials are a major growth driver. - The Association of the British Pharmaceutical Industry reported that UK pharmaceutical industry trials rose from 411 in 2022 to 426 in 2023.

Between the lines: - The market forecast suggests lab robotics is moving from a niche efficiency tool to a core infrastructure layer for modern labs. - Growth is strongest where labs need to scale output, standardize workflows and reduce variability. - Regional leadership still sits with North America, but the fastest gains appear likely in markets expanding healthcare capacity and automation adoption. - The report’s broader 2026 coverage, including TAM analysis and forecasting dashboards, points to increasing investor and strategic planning interest in the category.

What's next: - Market expansion is expected to continue as labs add automation to research, diagnostics and drug discovery workflows. - Adoption should accelerate in facilities investing in genomics, proteomics and clinical testing. - The company is offering a free sample of the report and access to the full report through its website. - More information is available in the sample report and the full market report.

The bottom line: - Laboratory robotics is on a steady growth path, powered by the push for faster, more accurate and more scalable lab operations.